France· FR:65845138
BIFONAZOLE SUBSTIPHARM 1 %, crème
A bifonazole product containing bifonazole, registered in France by SUBSTIPHARM, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Bifonazole is registered in 10 of 19 countries.
Countries holding a registration under ATC D01AC10 (bifonazole), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 5 of them publish a price we can compare per daily dose
Bifonazole · ATC D01AC10
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BIFONAZOLE
- Manufacturer
- SUBSTIPHARM
- Country
- France (FR)
- ATC code
- D01AC10
- ATC class
- Bifonazole
- Defined daily dose
- 10 mg, T
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009303044881 tube(s) aluminium laque époxyphénolique de 15 gEUR 2.4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bifonazole in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandCanesporBayer Sp. z o.o.
- SpainCANESMYCOSPOR 10 mg/g CREMABayer Hispania S.L.
- BelgiumCanestene Derm 1 %Bayer
- CzechiaCANESPOR 1X DENNĚBAYER s.r.o., Praha
- FinlandCanesporBayer Oy
- GermanyBifonDermapharm Ag
- United KingdomCanesten Bifonazole Once Daily Athlete's Foot 1% creamBayer Plc
- IrelandCanespor 10 mg/g creamBayer Limited
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Canesten
- Belgium · Canestene Derm
- Bulgaria · Бифоназол Абр, Канеспор
- Czechia · Canespor 1x Denně
- Germany · Bifon, Bifonazol Aristo
- Spain · Canesmycospor, Canespie
- Finland · Canespor
- United Kingdom (Northern Ireland) · Canesten Once Daily, Canesten Once Daily Athlete’s Foot
- Greece · Fungiderm 1% W/W Κρέμα
- Croatia · Canespor
- Hungary · Canesten Plus
- Ireland · Canespor
- Italy · Azolmen, Canesten Unidie
- Luxembourg · Canestene Derm
- Netherlands · Mycospor
- Poland · Canespor, Steper Pro
- Portugal · Bifonazol Farmoz, Canesten Unidia
- Romania · Biazol, Canespor
- Slovenia · Canespor
- Slovakia · Canespor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d191cbaa-8d07-416e-92af-9dc27e7beff0 GET /v1/drugs/d191cbaa-8d07-416e-92af-9dc27e7beff0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65845138",
"date_amm": "2024-10-29",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BIFONAZOLE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "crème",
"voies_administration": "cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about bifonazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.